Management ChangeJul 15, 2026, 04:27 PM

RxSight Appoints Aziz Mottiwala as CEO; Ron Kurtz Becomes CMO

AI Summary

RxSight, Inc. announced the appointment of Aziz Mottiwala as its new President and Chief Executive Officer, effective July 20, 2026. Mr. Mottiwala, who brings extensive commercial leadership experience in eye care, will also join the company's Board of Directors. Ron Kurtz, M.D., the outgoing CEO, will transition to serve as the company's Chief Medical Officer. Mr. Mottiwala's compensation package includes an annual base salary of $750,000, a target annual bonus of up to 90%, and new hire equity awards valued at $14 million.

Key Highlights

Aziz Mottiwala appointed President and Chief Executive Officer, effective July 20, 2026.
Ron Kurtz, M.D. transitions from President and CEO to Chief Medical Officer.
Mr. Mottiwala also appointed to the Board of Directors, replacing Dr. Kurtz.
Mr. Mottiwala's annual base salary is $750,000, with an annual bonus eligibility of up to 90%.
He will receive a 2026 cash bonus of $337,500.
Mr. Mottiwala was granted equity awards valued at $14,000,000 ($2M option, $12M RSUs).
Mr. Mottiwala previously served as Chief Commercial Officer at Tarsus Pharmaceuticals.

View SEC Filing

RXST

Ophthalmic Goods

RxSight, Inc.

Price Impact